Credit Suisse’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-20,900
Closed -$51K 3582
2021
Q4
$51K Buy
+20,900
New +$51K ﹤0.01% 3563
2021
Q1
Sell
-15,000
Closed -$26K 3489
2020
Q4
$26K Buy
+15,000
New +$26K ﹤0.01% 3436
2019
Q4
Sell
-27,342
Closed -$27K 3531
2019
Q3
$27K Buy
27,342
+3,759
+16% +$3.71K ﹤0.01% 3400
2019
Q2
$26K Sell
23,583
-4,202
-15% -$4.63K ﹤0.01% 3392
2019
Q1
$36K Buy
27,785
+12,334
+80% +$16K ﹤0.01% 3328
2018
Q4
$15K Buy
+15,451
New +$15K ﹤0.01% 3302
2018
Q3
Sell
-34,272
Closed -$62K 3361
2018
Q2
$62K Sell
34,272
-12,508
-27% -$22.6K ﹤0.01% 3418
2018
Q1
$110K Buy
46,780
+7,779
+20% +$18.3K ﹤0.01% 3363
2017
Q4
$73K Sell
39,001
-26,246
-40% -$49.1K ﹤0.01% 3378
2017
Q3
$162K Buy
65,247
+42,030
+181% +$104K ﹤0.01% 3501
2017
Q2
$64K Sell
23,217
-920
-4% -$2.54K ﹤0.01% 3369
2017
Q1
$73K Sell
24,137
-18,424
-43% -$55.7K ﹤0.01% 3342
2016
Q4
$134K Buy
42,561
+1,647
+4% +$5.19K ﹤0.01% 3539
2016
Q3
$139K Sell
40,914
-8,109
-17% -$27.5K ﹤0.01% 3535
2016
Q2
$112K Buy
+49,023
New +$112K ﹤0.01% 3726
2016
Q1
Sell
-16,459
Closed -$54K 3815
2015
Q4
$54K Sell
16,459
-1,496
-8% -$4.91K ﹤0.01% 3901
2015
Q3
$43K Sell
17,955
-2,619
-13% -$6.27K ﹤0.01% 3967
2015
Q2
$60K Buy
+20,574
New +$60K ﹤0.01% 4148
2015
Q1
Sell
-13,134
Closed -$40K 4128
2014
Q4
$40K Sell
13,134
-1,759
-12% -$5.36K ﹤0.01% 4145
2014
Q3
$37K Sell
14,893
-4,206
-22% -$10.4K ﹤0.01% 3967
2014
Q2
$47K Sell
19,099
-79,757
-81% -$196K ﹤0.01% 4165
2014
Q1
$263K Buy
98,856
+4,716
+5% +$12.5K ﹤0.01% 3812
2013
Q4
$274K Buy
94,140
+64,147
+214% +$187K ﹤0.01% 3691
2013
Q3
$92K Buy
29,993
+13,976
+87% +$42.9K ﹤0.01% 3683
2013
Q2
$51K Buy
+16,017
New +$51K ﹤0.01% 3693